Literature DB >> 20100090

Cytomegalovirus resistance testing: pitfalls and problems for the clinician.

W Lawrence Drew1.   

Abstract

In this review, I describe the available assays for detecting resistance of cytomegalovirus (CMV) to antivirals and emphasize the practical utility of the genotypic approach. The indications for such testing and the contraindications are discussed, as are the interpretation of results and the evidence of cross-resistance between antivirals.

Mesh：

Substances：

Year:  2010        PMID： 20100090     DOI： 10.1086/650463

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  11 in total

1.  The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase.

Authors:  Thomas Goldner; Guy Hewlett; Nicole Ettischer; Helga Ruebsamen-Schaeff; Holger Zimmermann; Peter Lischka
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

2.  Detection of cytomegalovirus drug resistance mutations by next-generation sequencing.

Authors:  Malaya K Sahoo; Martina I Lefterova; Fumiko Yamamoto; Jesse J Waggoner; Sunwen Chou; Susan P Holmes; Matthew W Anderson; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

3.  Human cytomegalovirus resistance to deoxyribosylindole nucleosides maps to a transversion mutation in the terminase subunit-encoding gene UL89.

Authors:  Brian G Gentry; Quang Phan; Ellie D Hall; Julie M Breitenbach; Katherine Z Borysko; Jeremy P Kamil; Leroy B Townsend; John C Drach
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

4.  Update on cytomegalovirus infections of the gastrointestinal system in solid organ transplant recipients.

Authors:  Tracy L Lemonovich; Richard R Watkins
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

5.  Incidence of refractory cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.

Authors:  Fumiaki Jinnouchi; Yasuo Mori; Goichi Yoshimoto; Takuji Yamauchi; Takuya Nunomura; Ayano Yurino; Masayasu Hayashi; Junichiro Yuda; Takahiro Shima; Jun Odawara; Shuichiro Takashima; Kenjiro Kamezaki; Koji Kato; Toshihiro Miyamoto; Koichi Akashi; Katsuto Takenaka
Journal:  Int J Hematol       Date:  2021-10-15       Impact factor: 2.490

6.  Emergence of antiviral resistance during oral valganciclovir treatment of an infant with congenital cytomegalovirus (CMV) infection.

Authors:  K Yeon Choi; B Sharon; H H Balfour; K Belani; T C Pozos; M R Schleiss
Journal:  J Clin Virol       Date:  2013-05-18       Impact factor: 3.168

Review 7.  Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation.

Authors:  Ajit P Limaye; Tara M Babu; Michael Boeckh
Journal:  Clin Microbiol Rev       Date:  2020-10-28       Impact factor: 26.132

Review 8.  Cytomegalovirus Treatment.

Authors:  Ban Hock Tan
Journal:  Curr Treat Options Infect Dis       Date:  2014

Review 9.  Emerging rapid resistance testing methods for clinical microbiology laboratories and their potential impact on patient management.

Authors:  Hagen Frickmann; Wycliffe Omurwa Masanta; Andreas E Zautner
Journal:  Biomed Res Int       Date:  2014-09-17       Impact factor: 3.411

Review 10.  Terminase Large Subunit Provides a New Drug Target for Herpesvirus Treatment.

Authors:  Linlin Yang; Qiao Yang; Mingshu Wang; Renyong Jia; Shun Chen; Dekang Zhu; Mafeng Liu; Ying Wu; Xinxin Zhao; Shaqiu Zhang; Yunya Liu; Yanling Yu; Ling Zhang; Xiaoyue Chen; Anchun Cheng
Journal:  Viruses       Date:  2019-03-05       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.